Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page
- Check5 days agoChange DetectedRevision version updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe history adds a new revision entry (v3.4.2) and removes the previous notices (v3.4.1). There are no changes to the study details or results.SummaryDifference1.0%

- Check40 days agoChange DetectedA site-wide notice about government funding and operating status was added to the page. The record version was updated from v3.4.0 to v3.4.1.SummaryDifference1.0%

- Check48 days agoChange DetectedThe update adds UI elements for the record history, including a glossary toggle, color-coded change highlights (green for additions and red crossed-out for deletions), and a new revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check83 days agoChange DetectedThe page shows a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link from the footer, updating the page metadata; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check105 days agoChange DetectedRecord History now shows Revision: v3.3.2 added and v3.3.1 removed.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.